New Ultrasound Technology Makes It Easy to Detect Middle Ear Infections
OtoNexus Medical Technologies has developed a new ultrasound technology platform. The first clinical application is a new otoscope that improves the detection of middle ear infections (Otitis Media). This new otitis media medical device helps primary care providers quickly and accurately identify the presence and type of middle ear infections (viral or bacterial) and determine the need for antibiotics in pediatric patients. Our goal is to provide clinicians with an accurate, simple-to-use tool to check for ear infections, which will enhance patient care, reduce unnecessary antibiotic use, and lower healthcare costs.
This new ultrasound technology is miniaturized, fits in the tip of an ear speculum, and is integrated into a small, portable otoscope. Unlike traditional visual inspection methods, which have not changed in decades, the new OtoNexus ultrasound otoscope uses through-air ultrasound (gel not needed) to quickly provide clear data on middle ear infections. It accurately detects acute otitis media and differentiates between viral and bacterial infections, which is crucial since bacterial infections require antibiotics, while viral infections do not. In addition, the new ultrasound otoscope can detect otitis media with effusion (OME) or fluid behind the eardrum without infection. This is important because persistent OME can significantly impact a child’s hearing. The ear ultrasound otoscope will provide clinicians with the data they need to detect the type of infection in the middle ear and determine the best treatment and management plan.
otitis media medical device by otonexus medical technologies for middle ear infection detection
OtoNexus Selected for Elite FDA Safer Technologies Program
The FDA Safer Technologies Program (STeP) is a new initiative by the FDA to speed up the development and review of innovative medical devices that greatly improve patient care and safety. The program helps patients access these devices more quickly by offering faster development, interactive communication, enhanced regulatory support, and real-time feedback. To qualify, a product must provide a significant advantage and superior solution over existing options. The FDA thoroughly evaluates the product technology and supporting clinical data to ensure it meets the program's strict criteria. Learn more.
Features otonexus ultrasound otoscope
The OtoNexus Solution
The OtoNexus ultrasound otoscope uses patented technology to determine the presence and type of middle ear infection. This groundbreaking technology provides a reliable, non-invasive method for detecting middle ear infections, setting a new standard in clinical diagnosis and filling a significant unmet need.
Key Ultrasound Otoscope Features:
Accuracy: Detects presence and type of middle ear infection.
Speed: Results in seconds, with a one-button push to instantly detect bacterial-infected middle ear effusion, reducing exam times
Efficiency: immediately determine the precise use of antibiotics to streamline care and optimize clinical workflow.
Connectivity: Seamless integration with EMR through wireless transfer exam results, images, and videos to simplify charting.
Potential Benefits:
Reduce Antibiotic Use: Helps clinicians to accurately distinguish between viral and bacterial middle ear infections, ensuring antibiotics are only prescribed when necessary.
Efficient Clinical Workflow: The OtoNexus ultrasound otoscope integrates seamlessly into the clinical workflow, providing immediate results that allow for confident, swift decision-making. This reduces the need for follow-up appointments and specialist referrals, saving healthcare providers and patients time and resources. Results, images, and videos transfer directly to patient records, streamlining the documentation process and enhancing workflow efficiency.
Improve Patient Outcomes: By providing quick and accurate data for clinicians, we may positively impact patient care by improving clinical outcomes, minimizing unnecessary antibiotic use, and reducing healthcare costs.
Dive Deeper Here to learn why detecting middle ear infections early and accurately is important.
Patented Technology and Recurring Revenue Model
OtoNexus has developed a patented ultrasound otoscope that represents a significant leap forward in medical diagnostics. The device not only offers capital equipment sales but also generates a recurring revenue stream through the sale of one-time-use disposable tips—essential consumables that ensure hygiene and provide a sustainable, profitable razor-and-blade business model.
Significant Market Opportunity
The market for the OtoNexus ultrasound otoscope is huge, with a multi-billion-dollar yearly revenue potential in the U.S. alone and even greater opportunities globally. This is a blue ocean market space with immense growth potential, as no other product on the market can identify bacterial middle ear infections with the precision and speed that our device offers. The ability to accurately detect bacterial infections provides the critical information physicians need to determine the appropriateness of antibiotic therapy—a capability that positions OtoNexus as a leader in reducing unnecessary antibiotic prescriptions.
Technology Platform Expansion Potential
Beyond its current application in detecting middle ear infections, the underlying ultrasound technology platform has additional potential for both medical and industrial uses, all of which are protected by patents. This opens up further avenues for growth and revenue diversification. Get more information here.
Proven Efficacy and FDA Validation
Our technology is grounded in verifiable science, with outstanding early clinical results demonstrating the device’s ability to detect bacterial infections in the middle ear. These results have earned OtoNexus a place in the FDA’s elite Safer Technologies Program (STeP), which fast-tracks innovative devices that provide a significant advantage over existing options. This selection not only validates our technology but also accelerates our path to market, ensuring timely adoption and patient access.
World-Class Leadership Team
OtoNexus is led by a highly accomplished, world-class team with deep expertise in medical device technology development, research and development, product commercialization, and scaling revenue growth. This leadership ensures that the company is well-equipped to navigate the complexities of the healthcare market, drive adoption, and achieve significant commercial success. Learn more about our team here.
Join the Revolution: Invest in Game-Changing Technology That Will Transform Healthcare for Generations
Invest in the future of medicine. Join us in our mission to improve the detection and treatment of middle ear infections with this groundbreaking technology that will revolutionize healthcare and shape generations to come. By choosing OtoNexus, you support a medtech innovator dedicated to significantly impacting patient care for pediatric patients and the broader healthcare system. Together, we can change the future of healthcare for children with the development of an ultrasound otoscope designed specifically for the accurate assessment of otitis media.
For more information about this unique medical device for otitis media management and our innovative technology, please explore our website for technology information and investment opportunities or complete the form below to contact us directly. Our medical device company is based just outside of Seattle, Washington.
Request Information
OtoNexus Medical Technologies is more than just a promising investment; it’s an opportunity to be part of a groundbreaking innovation in medical diagnostics with global implications.
Industry Awards and Recognition
otonexus medical technologies industry awards and recognition
OtoNexus Medical Technologies is honored to have received awards and recognition from Keiretsu Capital (Most Valued Company), Keiretsu Forum MidAtlantic (Most Valued Company), Keiretsu Forum Northwest (Most Valued Company), Red Herring (Top 100 North America) Angel Capital Association (Most Investable Company), Puget Sound Business Journal (Washington’s 100 Best Workplaces), MedTech Outlook (Top 10 Infection Control Solution Providers), MedTech Strategist (Startups to Watch), Silicon Review (Innovative Companies to Watch) and Women Corporate Directors (Winner Launch Zone). Please see the full details in our website NEWS.
Support and Non-Dilutive Funding
OToNexus Medical technologies company support and non-dilutive funding sources
OtoNexus Medical Technologies has received grants and/or support from the following institutions and groups: National Institutes of Health, National Science Foundation, State of Washington, Life Sciences Discovery Fund, Southwest Pediatric Device Consortium, Philadelphia Pediatric Medical Device Consortium, MedTech Innovator, Advanced Medical Technology Association, Future in Review, Consortium for Technology and Innovation in Pediatrics